A Preoperative MRI-Based Score to Predict High-Risk Pathology and Stratify Adjuvant Therapy Benefit in BCLC 0/A Hepatocellular Carcinoma
Huiying Li, Xinxin Wang, Can Yu, Baihe Li, Zhe Hu, Wanhu Li, Yueqin Chen, Yang Zhou, Yajuan Sun · 2026
Read A Preoperative MRI-Based Score to Predict High-Risk Pathology and Stratify Adjuvant Therapy Benefit in BCLC 0/A Hepatocellular Carcinoma by Huiying Li, Xinxin Wang, Can Yu, Baihe Li, Zhe Hu, Wanhu Li, Yueqin Chen, Yang Zhou, Yajuan Sun (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13207878.txt.
Description
Early liver cancer can hide aggressive traits, and a 2026 study authored by Huiying Li builds an MRI score to flag them before surgery. The multicenter retrospective study covers 994 patients with very early or early hepatocellular carcinoma who had contrast MRI and then curative resection at three institutions.
The score combines irregular tumor shape, a washout pattern, blood products inside the tumor, and a blood marker threshold. It predicted vessel invasion or high tumor grade with fair accuracy in training and validation groups in the authors' testing. Patients scoring positive relapsed sooner, and extra therapy after surgery appeared to help only that high-risk group.
Catalog record
| CREATOR | Huiying Li, Xinxin Wang, Can Yu, Baihe Li, Zhe Hu, Wanhu Li, Yueqin Chen, Yang Zhou, Yajuan Sun |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |